333 related articles for article (PubMed ID: 18536613)
1. The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).
Derriman L; Marshall J; Moorman C; Downes SM
Retina; 2008 Jun; 28(6):910; author reply 910-1. PubMed ID: 18536613
[No Abstract] [Full Text] [Related]
2. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.
Rinaldi M; Dell'Omo R; Romano MR; Chiosi F; Cipollone U; Costagliola C
Arch Ophthalmol; 2007 Oct; 125(10):1422-3. PubMed ID: 17923555
[No Abstract] [Full Text] [Related]
3. The effect of treatments given to patients before initiation of anti-vascular endothelial growth factor treatment.
Hedaya J; Freeman WR
Retina; 2008 Jun; 28(6):911-2; author reply 912. PubMed ID: 18536615
[No Abstract] [Full Text] [Related]
4. Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum.
Bhatnagar P; Freund KB; Spaide RF; Klancnik JM; Cooney MJ; Ho I; Fine HF; Yannuzzi LA
Retina; 2007 Sep; 27(7):897-902. PubMed ID: 17891014
[TBL] [Abstract][Full Text] [Related]
5. Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.
Teixeira A; Moraes N; Farah ME; Bonomo PP
Acta Ophthalmol Scand; 2006 Dec; 84(6):835-6. PubMed ID: 17083556
[No Abstract] [Full Text] [Related]
6. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.
Myung JS; Bhatnagar P; Spaide RF; Klancnik JM; Cooney MJ; Yannuzzi LA; Freund KB
Retina; 2010 May; 30(5):748-55. PubMed ID: 19996818
[TBL] [Abstract][Full Text] [Related]
7. Choroidal neovascularization in angioid streaks and pseudoxanthoma elasticum: 1 year follow-up.
Schiano Lomoriello D; Parravano MC; Chiaravalloti A; Varano M
Eur J Ophthalmol; 2009; 19(1):151-3. PubMed ID: 19123166
[TBL] [Abstract][Full Text] [Related]
8. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum.
Finger RP; Charbel Issa P; Schmitz-Valckenberg S; Holz FG; Scholl HN
Retina; 2011; 31(7):1268-78. PubMed ID: 21386758
[TBL] [Abstract][Full Text] [Related]
9. Retinal degeneration and persistent serous detachment in the absence of active choroidal neovascularization in pseudoxanthoma elasticum.
Hansen MS; Klefter ON; Larsen M
Acta Ophthalmol; 2014 Mar; 92(2):e156-7. PubMed ID: 24033986
[No Abstract] [Full Text] [Related]
10. Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bevacizumab.
Kovach JL; Schwartz SG; Hickey M; Puliafito CA
Ophthalmic Surg Lasers Imaging; 2009; 40(1):77-9. PubMed ID: 19205505
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.
Sawa M; Gomi F; Tsujikawa M; Sakaguchi H; Tano Y
Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288
[TBL] [Abstract][Full Text] [Related]
12. PSEUDOXANTHOMA ELASTICUM: SUCCESSFUL LONG-TERM MANAGEMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS WITH PRO RE NATA INTRAVITREAL BEVACIZUMAB INJECTIONS.
Kim J; Dalziel D
Retin Cases Brief Rep; 2021 May; 15(3):246-250. PubMed ID: 30048402
[TBL] [Abstract][Full Text] [Related]
13. Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.
Laud K; Spaide RF; Freund KB; Slakter J; Klancnik JM
Retina; 2006 Oct; 26(8):960-3. PubMed ID: 17031300
[No Abstract] [Full Text] [Related]
14. INTRAVITREAL BEVACIZUMAB IN THE TREATMENT OF CHOROIDAL NEOVASCULAR MEMBRANE DUE TO ANGIOID STREAKS.
Alagöz C; Alagöz N; Özkaya A; Çelik U; Turan MF; Yazici AT; Çekiç O; Demirok A
Retina; 2015 Oct; 35(10):2001-10. PubMed ID: 25996427
[TBL] [Abstract][Full Text] [Related]
15. Rapid progression of angioid streaks following intravitreal bevacizumab.
Sen PR; Rishi P; Sen P; Rishi E; Shroff D
Can J Ophthalmol; 2009 Oct; 44(5):e39-40. PubMed ID: 19798813
[No Abstract] [Full Text] [Related]
16. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab.
Teixeira A; Mattos T; Velletri R; Teixeira R; Freire J; Moares N; Bonomo PP
Ophthalmic Surg Lasers Imaging; 2010; 41(5):546-9. PubMed ID: 20795575
[TBL] [Abstract][Full Text] [Related]
17. An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report.
Karampelas M; Soumplis V; Karagiannis D; Parikakis E; Webster AR
BMC Res Notes; 2013 Dec; 6():530. PubMed ID: 24325973
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
Spandau UH; Jonas JB
Acta Ophthalmol Scand; 2007 May; 85(3):340-1. PubMed ID: 17488467
[No Abstract] [Full Text] [Related]
19. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
Bom Aggio F; Eid Farah M; Melo GB
Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
[No Abstract] [Full Text] [Related]
20. Angioid streaks in pseudoxanthoma elasticum.
Waqar M; Dhingra N
Postgrad Med J; 2019 Apr; 95(1122):220. PubMed ID: 30580324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
